covid 19 News and Research

RSS

How does the interval between the 1st and 2nd BNT162b2 doses impact the neutralization breadth and potency against variants of concern?

Scientists explored the influence of SARS-CoV-2 extended gap vaccination on the variants of concern neutralization.

9 Aug 2022

Evaluating vaccine effectiveness against Omicron BA.5 and BA.2 in Portugal

Researchers estimated the vaccine effectiveness (VE) of the primary and booster doses of COVID-19 vaccines against reinfection by Omicron BA.5 and BA.2 lineages and severe post-infection outcomes.

9 Aug 2022

How did perceived social support across COVID-19 restrictions alter alcohol and cannabis use in emerging adults?

Researchers demonstrated changes in alcohol and cannabis use among young adults in Canada and the United States during pre-COVID-19 times, COVID-19-induced lockdown, and when social restrictions eased later.

9 Aug 2022

Study suggests BA.5 evolved to induce enhanced inflammation when compared to prior Omicron subvariants

Researchers evaluated the comparative pathogenicity of SARS-CoV-2 Omicron sub-variants BA.1, BA.2, and BA.5, in vitro and in vivo.

9 Aug 2022

Study assesses the prevalence of gender-diverse youth in a rural region in Appalachia

Gender-diverse youth are at an increased risk of suicide and depression, according to the Centers for Disease Control and Prevention. But the prevalence of gender diversity is largely unknown-;especially in rural areas, where studies of the topic are rare.

9 Aug 2022

Researchers unravel a novel molecular target of eicosapentaenoic acid

Eicosapentaenoic acid (EPA) is an essential nutrient belonging to the omega-3 group of polyunsaturated fatty acids (PUFAs). As the human body cannot synthesize PUFAs, dietary supplements containing EPA are required for normal physiological functions. Found abundantly in natural sources like fish, hemp oil, and linseed oil, EPA is known to exhibit anti-inflammatory, neuroprotective, and cardiovascular protective activities.

9 Aug 2022

Serbia's genome center monitors potential virus mutations to facilitate more effective COVID-19 control

In partnership with BGI Genomics from China, Serbia's first genome sequencing center, opened in December 2021, is monitoring potential virus mutations to facilitate more effective COVID-19 control and accelerating access to genomics to enhance health outcomes.

9 Aug 2022

OU researchers receive nearly $1 million NSF grants for pandemic prediction and prevention projects

Two groups of researchers at the University of Oklahoma have each received nearly $1 million grants from the National Science Foundation as part of its Predictive Intelligence for Pandemic Prevention initiative, which focuses on fundamental research and capabilities needed to tackle grand challenges in infectious disease pandemics through prediction and prevention.

8 Aug 2022

Researchers develop a long-acting injectable formulation of the anti-TB drug rifabutin

In 2020, more than 1.5 million people around the world died of tuberculosis, marking the first time in more than a decade that annual TB deaths had increased and demonstrating the global need for better access to treatments.

8 Aug 2022

Should pregnant women be included clinical trials?

The current study reports some of the scientific, ethical, and legal considerations that will support the inclusion of pregnant women in future research.

8 Aug 2022

COVID-19 vaccination increases antibodies in breast milk significantly

Anti-SARS-CoV-2 antibodies in breast milk capable of neutralizing both an early pandemic SARS-CoV-2 isolate and Omicron variant.

8 Aug 2022

Sperm not affected nine months after COVID-19 mRNA vaccination

A recent study compared the effects of COVID-19 vaccines on male fertility at a median of nine months after receipt of two mRNA vaccine doses.

8 Aug 2022

Study tests equine polyclonal antibodies against SARS-CoV-2 variants

A recent study published tested equine polyclonal antibodies against SARS-CoV-2.

8 Aug 2022

Inhaled aprotinin found to reduce viral load in mild-to-moderate COVID-19

A recent paper describes the use of aprotinin, a protease inhibitor that works across several pathways, to reduce the severity of COVID-19.

8 Aug 2022

The safety and preliminary efficacy of OP-101 in patients with severe COVID-19

Researchers assessed the impact of dendrimer nanotherapy in treating severe COVID-19.

8 Aug 2022

The impact of cold agglutinin syndrome on clinical presentations in COVID-19

Researchers presented two cases to highlight the impact of cold agglutinin syndrome on clinical presentations in COVID-19.

8 Aug 2022

Fatigue and headache among the most common symptoms following COVID-19 infections

Fatigue and headache were the most common symptoms reported by individuals an average of more than four months out from having COVID-19, investigators report.

8 Aug 2022

What is the impact of SARS-CoV-2 Omicron BA.2 breakthrough infection on novel Omicron sublineages?

In a new study, investigators examined if SARS-CoV-2 Omicron BA.2 breakthrough infection in triple vaccinated individuals boosts Omicron BA.4/BA.5 and BA.2.12.1 cross-neutralization.

8 Aug 2022

Suicidal ideation may have increased significantly during COVID-19 lockdown

The lockdowns during the COVID-19 pandemic had a significant effect on levels of suicidal ideation, a new study finds.

8 Aug 2022

Researchers identify new therapies that could provide better protection against future COVID-19 variants

Researchers from the University of Kent in Canterbury, UK and the Goethe-University in Frankfurt am Main have identified new therapies for COVID-19 that could provide better protection against future variants and outbreaks.

8 Aug 2022

covid 19 News and Research

How does the interval between the 1st and 2nd BNT162b2 doses impact the neutralization breadth and potency against variants of concern?

Evaluating vaccine effectiveness against Omicron BA.5 and BA.2 in Portugal

How did perceived social support across COVID-19 restrictions alter alcohol and cannabis use in emerging adults?

Study suggests BA.5 evolved to induce enhanced inflammation when compared to prior Omicron subvariants

Study assesses the prevalence of gender-diverse youth in a rural region in Appalachia

Researchers unravel a novel molecular target of eicosapentaenoic acid

Serbia's genome center monitors potential virus mutations to facilitate more effective COVID-19 control

OU researchers receive nearly $1 million NSF grants for pandemic prediction and prevention projects

Researchers develop a long-acting injectable formulation of the anti-TB drug rifabutin

Should pregnant women be included clinical trials?

COVID-19 vaccination increases antibodies in breast milk significantly

Sperm not affected nine months after COVID-19 mRNA vaccination

Study tests equine polyclonal antibodies against SARS-CoV-2 variants

Inhaled aprotinin found to reduce viral load in mild-to-moderate COVID-19

The safety and preliminary efficacy of OP-101 in patients with severe COVID-19

The impact of cold agglutinin syndrome on clinical presentations in COVID-19

Fatigue and headache among the most common symptoms following COVID-19 infections

What is the impact of SARS-CoV-2 Omicron BA.2 breakthrough infection on novel Omicron sublineages?

Suicidal ideation may have increased significantly during COVID-19 lockdown

Researchers identify new therapies that could provide better protection against future COVID-19 variants

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News